文献速递类风湿关节炎

美国类风湿关节炎患者高脂血症筛查现状

Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2019-01-01

该研究分析2006-2010年美国私人和公共健康计划索赔数据,纳入330,695名符合条件的参与者,评估类风湿关节炎(RA)患者接受血脂筛查的比例,并与糖尿病(DM)患者及无RA无DM人群比较。结果显示RA患者筛查比例为37%,低于DM患者的60%和RA合并DM患者的55%,仅略低于无RA无DM人群的41%。同时就诊风湿科和非风湿科医生的RA患者筛查概率比仅就诊风湿科者高55%(95%CI 1.36-1.78)。

要点

  • RA患者血脂筛查比例37%,低于DM患者60%和一般人群41%。
  • 同时看风湿科和非风湿科医生的RA患者筛查概率提高55%。
  • RA患者血脂筛查不充分,需加强跨专科协作。

核心结论

  • RA患者接受初级血脂筛查的比例不理想,且低于DM患者,与一般人群差异不大。
  • 同时接受风湿科和非风湿科医生诊疗的RA患者血脂筛查概率更高。

研究设计与样本

  • 基于2006-2010年美国私人和公共健康计划索赔数据的回顾性队列分析,共纳入330,695名符合条件的参与者。
  • 纳入标准包括连续医疗和药房覆盖≥12个月,以及>2次医生诊断和相关药物定义RA、DM、RA合并DM或无此两种疾病。

主要发现

  • RA患者(n=12,182)血脂筛查比例为37%,DM患者(n=62,834)为60%,RA合并DM患者(n=1,082)为55%,无RA无DM者(n=167,811)为41%。
  • 同时就诊风湿科和非风湿科医生的RA患者,其血脂筛查概率比仅就诊风湿科者高55%(95%CI 1.36-1.78)。

临床怎么用

  • 风湿免疫科医生应重视RA患者的血脂筛查,必要时与初级保健医生协作提高筛查率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the proportion of primary lipid screening among patients with rheumatoid arthritis (RA) and compare it with those among patients with diabetes mellitus (DM) and patients with neither RA nor DM, and to assess whether primary lipid screening varied according to the health care provider (rheumatologist versus non-rheumatologist). METHODS: We analyzed claims data from US private and public health plans from 2006-2010. Eligibility requirements included continuous medical and pharmacy coverage for ≥12 months (baseline period) and >2 physician diagnoses and relevant medications to define RA, DM, RA and DM, or neither condition. Among the 330,695 eligible participants, we calculated the proportion with a lipid profile ordered during the 2 years following baseline. Time-varying Cox proportional hazard models were used to determine the probability of hyperlipidemia screening in participants with RA according to provider specialty. RESULTS: More than half of the patients were ages 41-71 years. Among patients with RA (n = 12,182), DM (n = 62,834), RA and DM (n = 1,082), and those who did not have either condition (n = 167,811), the proportion screened for hyperlipidemia was 37%, 60%, 55%, and 41%, respectively. Patients with RA who visited a rheumatologist and a non-rheumatology clinician during follow-up had a 55% (95% confidence interval 1.36-1.78) higher screening probability than those who only visited a rheumatologist. CONCLUSION: Primary lipid screening was suboptimal among patients with RA. It was also lower for patients with DM and minimally different from the general population. Screening was higher for RA patients who received care from both a rheumatologist and a non-rheumatologist (e.g., primary care physician).

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Navarro-Millán I, Yang S, Chen L, et al. Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States. Arthritis Care Res (Hoboken). 2019. PMID: 30414353. doi:10.1002/acr.23810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。